From the literature – Pannash

Category: From the literature

This is our archive page

PPAR’s as critical regulators of metabolism

20 November 2020, by D. Beard

The changing global epidemiology of hepatocellular carcinoma

20 November 2020, by G. Bozet, MD

Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes

20 November 2020, by G. Bozet, MD

Non-alcoholic fatty liver disease and alcohol-related liver disease: Two intertwined entities

11 November 2020, by G. Bozet, MD

Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease

11 November 2020, by G. Bozet, MD

Automated thermal imaging for the detection of fatty liver disease

5 November 2020, by D. Beard

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease

5 November 2020, by D. Beard

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease

29 October 2020, by D. Beard

Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

29 October 2020, by D. Beard

Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus

23 October 2020, by D. Beard